↓ Skip to main content

Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, February 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent
2 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
36 Mendeley
Title
Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro
Published in
Cancer Chemotherapy and Pharmacology, February 2009
DOI 10.1007/s00280-009-0935-7
Pubmed ID
Authors

Seongwook Jeong, Margaret M. Woo, David A. Flockhart, Zeruesenay Desta

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 3%
United Kingdom 1 3%
United States 1 3%
Unknown 33 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 25%
Student > Ph. D. Student 6 17%
Professor 4 11%
Student > Bachelor 3 8%
Professor > Associate Professor 3 8%
Other 6 17%
Unknown 5 14%
Readers by discipline Count As %
Chemistry 7 19%
Pharmacology, Toxicology and Pharmaceutical Science 6 17%
Medicine and Dentistry 6 17%
Agricultural and Biological Sciences 5 14%
Biochemistry, Genetics and Molecular Biology 4 11%
Other 2 6%
Unknown 6 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2023.
All research outputs
#4,972,158
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#244
of 2,501 outputs
Outputs of similar age
#27,726
of 175,191 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#5
of 23 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.